S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Facing increasing pressure from customers, some miners are switching to renewable energy
66,000% upside on tiny biotech? (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Facing increasing pressure from customers, some miners are switching to renewable energy
66,000% upside on tiny biotech? (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Facing increasing pressure from customers, some miners are switching to renewable energy
66,000% upside on tiny biotech? (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
66,000% upside on tiny biotech? (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
66,000% upside on tiny biotech? (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Facing increasing pressure from customers, some miners are switching to renewable energy
66,000% upside on tiny biotech? (Ad)
The death toll in a collapsed gold mine in Zimbabwe expected to rise to 13, vice president says
Rishi Sunak needs to rally his flagging Conservatives. He hopes a dash of populism will do the trick
NASDAQ:ORIC

ORIC Pharmaceuticals (ORIC) Earnings Date, Estimates & Call Transcripts

$6.05
-0.08 (-1.31%)
(As of 09/29/2023 ET)
Compare
Today's Range
$5.88
▼
$6.30
50-Day Range
$6.05
▼
$9.28
52-Week Range
$2.36
▼
$9.79
Volume
756,624 shs
Average Volume
374,652 shs
Market Capitalization
$329.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Nov. 6Estimated
Actual EPS
(Aug. 10)
-$0.50 Beat By $0.08
Consensus EPS
(Aug. 10)
-$0.58
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ORIC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ORIC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ORIC Pharmaceuticals Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.51)($0.51)($0.51)
Q2 20231($0.59)($0.59)($0.59)
Q3 20231($0.42)($0.42)($0.42)
Q4 20231($0.44)($0.44)($0.44)
FY 20234($1.96)($1.96)($1.96)
Q1 20241($0.46)($0.46)($0.46)
Q2 20241($0.48)($0.48)($0.48)
Q3 20241($0.50)($0.50)($0.50)
Q4 20241($0.52)($0.52)($0.52)
FY 20244($1.96)($1.96)($1.96)

ORIC Earnings Date and Information

ORIC Pharmaceuticals last issued its quarterly earnings results on August 10th, 2023. The reported ($0.50) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.08. ORIC Pharmaceuticals has generated ($2.18) earnings per share over the last year (($2.18) diluted earnings per share). Earnings for ORIC Pharmaceuticals are expected to decrease in the coming year, from ($1.96) to ($2.02) per share. ORIC Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off prior year's report dates.

ORIC Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/6/2023
Estimated)		------- 
8/10/2023Q2 2023($0.58)($0.50)+$0.08($0.50)--
5/8/2023Q1 2023($0.54)($0.53)+$0.01($0.53)--
3/16/2023Q4 2022($0.56)($0.52)+$0.04($0.52)--
11/7/2022Q3 2022($0.55)($0.63)($0.08)($0.63)--
8/11/2022Q2 2022($0.60)($0.51)+$0.09($0.51)--
5/9/2022Q1 2022($0.57)($0.59)($0.02)($0.59)--  
3/21/2022Q4 2021($0.61)($0.58)+$0.03($0.58)--    
11/8/2021Q3 2021($0.58)($0.47)+$0.11($0.47)--
8/10/2021Q2 2021($0.49)($0.57)($0.08)($0.57)--
5/6/2021Q1 2021($0.48)($0.45)+$0.03($0.45)--  
3/22/2021Q4($0.4640)($0.84)($0.3760)($0.84)--
11/5/2020Q3 2020($0.39)($0.84)($0.45)($0.84)--  












ORIC Pharmaceuticals Earnings - Frequently Asked Questions

When is ORIC Pharmaceuticals's earnings date?

ORIC Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 6th, 2023 based off last year's report dates. Learn more on ORIC's earnings history.

Did ORIC Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, ORIC Pharmaceuticals (NASDAQ:ORIC) reported ($0.50) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.58) by $0.08. Learn more on analysts' earnings estimate vs. ORIC's actual earnings.

How much profit does ORIC Pharmaceuticals generate each year?

ORIC Pharmaceuticals (NASDAQ:ORIC) has a recorded net income of -$89.12 million. ORIC has generated -$2.18 earnings per share over the last four quarters.

What is ORIC Pharmaceuticals's EPS forecast for next year?

ORIC Pharmaceuticals's earnings are expected to decrease from ($1.96) per share to ($2.02) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ORIC) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -